BEAM logo

Beam Therapeutics Inc. (BEAM) Cash From Investing

Annual CFI:

$185.01M+$113.17M(+157.53%)
December 31, 2024

Summary

  • As of today, BEAM annual cash from investing is $185.01 million, with the most recent change of +$113.17 million (+157.53%) on December 31, 2024.
  • During the last 3 years, BEAM annual cash from investing has risen by +$479.15 million (+162.90%).
  • BEAM annual cash from investing is now at all-time high.

Performance

1-Year Change

+157.53%

3-Year Change

+162.9%

5-Year Change

+377.54%

15-Year Change

+53570.23%

BEAM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

97.89%
BEAM annual cash from investing is higher than 97.89% of companies in Healthcare sector

Range

All-Time High

$185.01M
BEAM annual cash from investing is currently at an all-time high

3-Year Low

-$461.34M
BEAM annual cash from investing is currently +140.10% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BEAM previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 24, 2026
BEAM next annual earnings announcement is scheduled for Feb 24, 2026

OtherBEAMcash flow metrics

Annual CFF

$7.74M
BEAM annual cash from financing is $7.74 million

Annual CFO

-$347.25M
BEAM annual cash from operations is -$347.25 million

Annual FCF

-$356.19M
BEAM annual free cash flow is -$356.19 million

Annual CAPEX

$8.95M
BEAM annual capital expenditures is $8.95 million

Quarterly CFI:

$65.66M+$236.07M(+138.53%)
September 30, 2025

Summary

  • As of today, BEAM quarterly cash from investing is $65.66 million, with the most recent change of +$236.07 million (+138.53%) on September 30, 2025.
  • Over the past year, BEAM quarterly cash from investing has increased by +$40.96 million (+165.83%).
  • BEAM quarterly cash from investing is now -48.01% below its all-time high of $126.28 million, reached on December 31, 2024.

Performance

3-Month Change

+138.53%

1-Year Change

+165.83%

3-Year Change

+281.5%

5-Year Change

+86.37%

BEAM Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

96.38%
BEAM quarterly cash from investing is higher than 96.38% of companies in Healthcare sector

Range

All-Time High

$126.28M
BEAM quarterly cash from investing is currently -48.01% below its historical high of $126.28 million

3-Year Low

-$170.41M
BEAM quarterly cash from investing is currently +138.53% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BEAM previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 24, 2026
BEAM next earnings announcement is scheduled for Feb 24, 2026

OtherBEAMcash flow metrics

Quarterly CFF

$1.68M
BEAM quarterly cash from financing is $1.68 million

Quarterly CFO

-$81.48M
BEAM quarterly cash from operations is -$81.48 million

Quarterly FCF

-$86.49M
BEAM quarterly free cash flow is -$86.49 million

Quarterly CAPEX

$5.01M
BEAM quarterly capital expenditures is $5.01 million

TTM CFI:

-$103.56M+$40.96M(+28.34%)
September 30, 2025

Summary

  • As of today, BEAM TTM cash from investing is -$103.56 million, with the most recent change of +$40.96 million (+28.34%) on September 30, 2025.
  • Over the past year, BEAM TTM cash from investing has dropped by -$260.39 million (-166.04%).
  • BEAM TTM cash from investing is now -155.98% below its all-time high of $185.01 million, reached on December 31, 2024.

Performance

3-Month Change

+28.34%

1-Year Change

-166.04%

3-Year Change

+84.12%

5-Year Change

-4746.28%

BEAM TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

16.02%
BEAM TTM cash from investing is higher than 16.02% of companies in Healthcare sector

Range

All-Time High

$185.01M
BEAM TTM cash from investing is currently -155.98% below its historical high of $185.01 million

3-Year Low

-$652.27M
BEAM TTM cash from investing is currently +84.12% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BEAM previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 24, 2026
BEAM next earnings announcement is scheduled for Feb 24, 2026

OtherBEAMcash flow metrics

TTM CFF

$479.61M
BEAM TTM cash from financing is $479.61 million

TTM CFO

-$338.18M
BEAM TTM cash from operations is -$338.18 million

TTM FCF

-$352.36M
BEAM TTM free cash flow is -$352.36 million

TTM CAPEX

$14.18M
BEAM TTM capital expenditures is $14.18 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BEAM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+157.5%+165.8%-166.0%
3Y3 Years+162.9%+281.5%+84.1%
5Y5 Years+377.5%+86.4%-4746.3%

BEAM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+140.1%-48.0%+138.5%-156.0%+84.1%
5Y5-Yearat high+140.1%-48.0%+112.2%-156.0%+84.1%
All-TimeAll-Timeat high+140.1%-48.0%+112.2%-156.0%+84.1%

BEAM Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$65.66M(+138.5%)
-$103.56M(+28.3%)
Jun 2025
-
-$170.41M(-36.2%)
-$144.52M(-227.5%)
Mar 2025
-
-$125.09M(-199.1%)
$113.38M(-38.7%)
Dec 2024
$185.01M(+157.5%)
$126.28M(+411.3%)
$185.01M(+18.0%)
Sep 2024
-
$24.70M(-71.8%)
$156.83M(+28.7%)
Jun 2024
-
$87.49M(+263.6%)
$121.90M(+1822.9%)
Mar 2024
-
-$53.46M(-154.5%)
-$7.08M(-109.8%)
Dec 2023
$71.84M(+115.6%)
$98.10M(+1058.9%)
$71.84M(-17.6%)
Sep 2023
-
-$10.23M(+75.3%)
$87.18M(+42.4%)
Jun 2023
-
-$41.48M(-263.0%)
$61.24M(-39.6%)
Mar 2023
-
$25.45M(-77.6%)
$101.45M(+122.0%)
Dec 2022
-$461.34M
$113.44M(+413.6%)
-$461.34M(+29.3%)
Sep 2022
-
-$36.17M(-2766.4%)
-$652.27M(-20.8%)
Jun 2022
-
-$1.26M(+99.8%)
-$539.98M(+2.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$537.34M(-593.4%)
-$551.86M(-87.6%)
Dec 2021
-$294.14M(-193.8%)
-$77.50M(-201.8%)
-$294.14M(+1.3%)
Sep 2021
-
$76.11M(+679.4%)
-$298.07M(+12.1%)
Jun 2021
-
-$13.14M(+95.3%)
-$338.96M(-11.9%)
Mar 2021
-
-$279.63M(-243.4%)
-$302.96M(-202.6%)
Dec 2020
-$100.12M(-50.2%)
-$81.43M(-331.1%)
-$100.12M(-4585.2%)
Sep 2020
-
$35.23M(+54.0%)
-$2.14M(+90.8%)
Jun 2020
-
$22.87M(+129.8%)
-$23.15M(+83.6%)
Mar 2020
-
-$76.79M(-563.7%)
-$141.10M(-111.7%)
Dec 2019
-$66.66M(-396.6%)
$16.56M(+16.5%)
-$66.66M(+29.4%)
Sep 2019
-
$14.21M(+114.9%)
-$94.44M(+13.1%)
Jun 2019
-
-$95.08M(-3939.0%)
-$108.65M(-700.4%)
Mar 2019
-
-$2.35M(+79.0%)
-$13.57M(-21.0%)
Dec 2018
-$13.42M(-3779.8%)
-$11.22M
-$11.22M
Dec 2017
-$346.00K
-
-

FAQ

  • What is Beam Therapeutics Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. annual cash from investing year-on-year change?
  • What is Beam Therapeutics Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. quarterly cash from investing year-on-year change?
  • What is Beam Therapeutics Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. TTM cash from investing year-on-year change?

What is Beam Therapeutics Inc. annual cash from investing?

The current annual cash from investing of BEAM is $185.01M

What is the all-time high annual cash from investing for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high annual cash from investing is $185.01M

What is Beam Therapeutics Inc. annual cash from investing year-on-year change?

Over the past year, BEAM annual cash from investing has changed by +$113.17M (+157.53%)

What is Beam Therapeutics Inc. quarterly cash from investing?

The current quarterly cash from investing of BEAM is $65.66M

What is the all-time high quarterly cash from investing for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high quarterly cash from investing is $126.28M

What is Beam Therapeutics Inc. quarterly cash from investing year-on-year change?

Over the past year, BEAM quarterly cash from investing has changed by +$40.96M (+165.83%)

What is Beam Therapeutics Inc. TTM cash from investing?

The current TTM cash from investing of BEAM is -$103.56M

What is the all-time high TTM cash from investing for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high TTM cash from investing is $185.01M

What is Beam Therapeutics Inc. TTM cash from investing year-on-year change?

Over the past year, BEAM TTM cash from investing has changed by -$260.39M (-166.04%)
On this page